REFERENCES
- Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990; 186:1–85.
- Kakhlon O, Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in celullar processes. Free Radic Biol Med. 2002; 33(8):1037–1046.
- Baliga R, Ueda N, Walker PD, Shah SV. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev. 1999; 31(4):971–997.
- Ueda N, Mayeux PR, Baliga R, Shah SV. Oxidant mechanisms in acute renal failure. In: Molitoris B, Finn W, ed. Acute Renal Failure: A Companion to Brenner & Rector’s The Kidney. Philadelphia: W.B. Saunders Company; 2001:60–77.
- Mehta RL, Kellum JA, Shah SV, Acute kidney injury network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11(2):R31.
- Chertow GM, Burdick E, Honour M, Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005; 16(11):3365–3370.
- Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol. 1988; 255(24):F539–F544.
- Rajapurkar M, Gang S, Hegde U, Study of urinary catalytic (bleomycin-detectable) iron following radiocontrast exposure in healthy kidney donors. J Am Soc Nephrol. 2007; 18(Abstracts issue):575A.
- Hanss BG, Valencia SH, Shah SV, Vari RC. The iron chelator deferoxamine prevents contrast media induced acute renal failure in the rabbit. J Am Soc Nephrol. 1990; 1(4):612.
- Shah SV, Baliga R, Fonseca VA, Rajapurkar M. Oxidants in chronic kidney disease. J Am Soc Nephrol. 2007; 18(1):16–28.
- Rajapurkar MM, Alam MG, Bhattacharya A. Novel treatment for diabetic nephropathy. J Am Soc Nephrol. 2007; 18(Abstracts issue):329A.
- Nankivell BJ, Boadle RA, Harris DCH. Iron accumulation in human chronic renal disease. Am J Kidney Dis. 1992; 20(6):580–504.
- Lin J-L, Lin-Tan D-T, Hsu K-H, Yu C-C. Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med. 2003; 348(4):277–286.
- Owda AK, Alam MG, Shah SV. Environmental lead exposure and chronic renal disease (letter). N Engl J Med. 2003; 348(18):1810.
- Rajapurkar MM, Baliga R, Shah SV. Treatment of patients with glomerulonephritis with an oral iron chelator. J Am Soc Nephrol. 2007; 18(Abstracts issue):57–58A.